Angiotensin converting enzyme-2 as therapeutic target in COVID-19

dc.creatorRoshanravan, Neda
dc.creatorGhaffari, Samad
dc.creatorHedayati, Mehdi
dc.date.accessioned2020-07-27T21:06:14Z
dc.date.accessioned2022-09-23T18:43:33Z
dc.date.available2020-07-27T21:06:14Z
dc.date.available2022-09-23T18:43:33Z
dc.date.created2020-07-27T21:06:14Z
dc.identifier1871-4021
dc.identifierhttps://www.sciencedirect.com/science/article/pii/S1871402120301417?via%3Dihub
dc.identifierhttp://hdl.handle.net/20.500.12010/11237
dc.identifierhttps://doi.org/10.1016/j.dsx.2020.05.022
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3506255
dc.publisherDiabetes & Metabolic Syndrome: Clinical Research & Reviews
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCOVID-19
dc.titleAngiotensin converting enzyme-2 as therapeutic target in COVID-19


Este ítem pertenece a la siguiente institución